Jin Rong Jie

Search documents
瑞和数智(03680.HK)拟通过开展加密货币业务拓展收入来源
Jin Rong Jie· 2025-08-26 04:25
Group 1 - The company 瑞和数智 (03680.HK) announced plans to diversify its revenue sources by engaging in cryptocurrency business through cloud mining services provided by Bitmain, an independent third-party service provider [1] - The service provider and its ultimate beneficial owners are known to be independent third parties of the company [1]
三一装备取得起重机超起半径控制相关专利
Jin Rong Jie· 2025-08-26 04:25
Group 1 - The core viewpoint of the article highlights that Zhejiang SANY Equipment Co., Ltd. has obtained a patent for a crane control method and device, indicating innovation in the manufacturing sector [1] - The patent, titled "Crane Super Radius Control Method, Device and Crane," was authorized with announcement number CN112723172B, and the application date was January 2021 [1] - Zhejiang SANY Equipment Co., Ltd. was established in 2008 and is located in Huzhou, primarily engaged in other manufacturing industries [1] Group 2 - The company has a registered capital of 43.18 million RMB [1] - According to data analysis, Zhejiang SANY Equipment has invested in 7 enterprises and participated in 2,346 bidding projects [1] - The company holds 966 patent records and has 26 administrative licenses [1]
腾讯取得搜索引擎的查询优化方法相关专利
Jin Rong Jie· 2025-08-26 04:25
Group 1 - Tencent Technology (Shenzhen) Co., Ltd. has obtained a patent for a "query optimization method, device, and electronic equipment for search engines," with the authorization announcement number CN113407807B, and the application date was December 2020 [1] - Tencent Technology (Shenzhen) Co., Ltd. was established in 2000 and is located in Shenzhen, primarily engaged in software and information technology services, with a registered capital of 2 million USD [1] - The company has invested in 15 enterprises, participated in 264 bidding projects, and has 5,000 trademark records and 5,000 patent records, along with 534 administrative licenses [1]
豆神教育:学伴机器人计划本年四季度上市批量销售
Jin Rong Jie· 2025-08-26 04:17
针对上述提问,豆神教育回应称:"您好,公司的学伴机器人已于2025年7月亮相公司新产品发布会,计 划在本年四季度上市批量销售,欢迎广大投资者持续关注公司的产品动态与战略进展。公司提醒广大投 资者从研发到实际量产上市仍存在一定的不确定性,后续进展请以公司对外官方发布内容为准。公司提 醒广大投资者注意投资风险,感谢您们的关注和支持。"责任编辑:栎树 金融界8月26日消息,有投资者在互动平台向豆神教育提问:"公司的学伴机器人什么时候才正式上 市?" ...
赛目科技(02571.HK)中期扭亏为盈 溢利131.6万元
Jin Rong Jie· 2025-08-26 04:12
Core Insights - The company, Saimo Technology (02571.HK), reported a revenue of 90.959 million RMB for the six months ending June 30, 2025, representing a year-on-year growth of 63.7% [1] - The profit attributable to the company's owners was 1.316 million RMB, a significant improvement compared to a loss of 4.743 million RMB in the same period of 2024 [1] - Earnings per share stood at 0.01 RMB, and the company did not declare an interim dividend [1]
港股午评:恒指跌0.22%、科指涨0.27%,黄金及苹果概念股走高,药品关税令生物医药概念股普跌
Jin Rong Jie· 2025-08-26 04:12
金融界8月26日消息,周二,港股市场低开后震荡续上行,截止午盘,恒生指数跌0.22%报25773.56点, 恒生科技指数涨0.27%报5840.71点,国企指数跌0.11%报9237.89点,红筹指数跌0.43%报4369.65点。 盘面上,大型科技股部分由跌转涨,网易、快手、小米、腾讯均翻红,阿里巴巴仍跌超1%,美团、百 度小幅走低;美联储转"鸽",降息预期下金价上涨逻辑更为清晰,黄金股带领有色金属股齐涨,中国黄 金国际、灵宝黄金涨超6%;9月新品催化苹果概念股普升,高伟电子、蓝思科技领涨;濠赌股拉升,金 界控股绩后放量大涨超19%表现最佳,且刷新阶段新高,汽车股、纸业股、乳制品股、航空股多数上 涨。另一方面,特朗普称将迅速对药品征收关税,生物医药股普遍走低,信达生物、石药集团等创新药 概念股齐跌;昨日上海调整限购,分析指市场更需要的是"持续添柴",昨日走强的内房股普跌,军工 股、中资券商股、半导体芯片股表现低迷。 企业新闻 海底捞(06862.HK):上半年收入207.03亿元,同比下降3.7%;净利润17.6亿元,同比下跌13.7%。 钧达股份(02865.HK):上半年收入约36.56亿元,同比减少4 ...
摩根大通:预期澳门8月博彩总收入至多达225亿澳门元,有望再次突破疫情后纪录
Jin Rong Jie· 2025-08-26 04:12
Core Insights - Morgan Stanley's report indicates that Macau's gaming revenue (GGR) for the first 24 days of August reached MOP 17.65 billion, with an average daily revenue of MOP 735 million [1] - The average daily revenue for the previous week increased by 9% to MOP 793 million compared to the week before, while the average daily revenue for the first 17 days of August was MOP 710 million, and MOP 714 million in July, marking the highest record since the pandemic outside of peak periods [1] - The report anticipates that total gaming revenue for August will grow by 11% to 14%, reaching between MOP 21.9 billion and MOP 22.5 billion, potentially breaking post-pandemic records again [1]
港股异动 晋景新能(01783)再涨超7% 公司获纳入恒生综合指数 多家大行预计其后续进入港股通
Jin Rong Jie· 2025-08-26 04:06
Core Viewpoint - Jin Jing New Energy (01783) has seen a significant increase of over 7%, currently trading at 8.86 HKD with a transaction volume of 16.2456 million HKD, following its inclusion in the Hang Seng Composite Index [1] Group 1 - The Hang Seng Index Company announced its semi-annual index adjustment results on August 22, which included Jin Jing New Energy as a constituent stock [1] - The adjustment will take effect after the market closes on September 5 and will be effective from September 8 [1] - Analysts from UBS, CICC, and Shenwan Hongyuan have predicted that Jin Jing New Energy is likely to be included in the Hong Kong Stock Connect list [1] Group 2 - The inclusion in the index is expected to attract more southbound capital and passive funds, such as index funds, leading to a significant increase in short-term liquidity for Jin Jing New Energy [1]
港股异动 荣昌生物(09995)再涨超4% 公司上半年减亏显著 机构看好其长期发展潜力
Jin Rong Jie· 2025-08-26 04:06
Core Viewpoint - Rongchang Biologics (09995) has seen a stock price increase of over 4%, currently trading at 92.4 HKD with a transaction volume of 625 million HKD, following the announcement of its mid-2025 performance results [1] Financial Performance - The company reported product sales and R&D service revenue of 1.092 billion RMB, representing a year-on-year increase of 47.6% [1] - R&D expenses decreased by 19.7% to 647 million RMB, while the net loss was approximately 450 million RMB, a reduction of 42.4% year-on-year [1] Product Performance - The revenue increase is primarily attributed to the strong sales growth of its autoimmune commercial product, Taitasip, and the oncology commercial product, Vidisilimab [1] - Core product sales are expected to continue steady growth, with an anticipated annual revenue increase of over 30% [1] Market Outlook - The company is poised for long-term growth, with the potential commercialization of RC28 upon achieving licensing [1] - The international expansion of Taitasip is expected to enhance its competitiveness in indications such as MG, while the Phase III trial of Vidisilimab is accelerating [1] - Positive efficacy signals have been observed for RC148 in IO-resistant patients, and there is demand from multiple multinational corporations (MNCs) for PD-1/VEGF dual antibodies, indicating strong overseas potential [1]
盟升转债盘中下跌2.01%报241.382元/张,成交额1.77亿元,转股溢价率20.32%
Jin Rong Jie· 2025-08-26 04:02
可转换债券简称可转债,是一种可以在特定时间、按特定条件转换为普通股票的特殊企业债券,兼具债 权和股权的特征。一般而言,持有人可按照发行时约定的价格将债券转换成公司的普通股票的债券。如 果债券持有人不想转换,则可以继续持有债券,直到偿还期满时收取本金和利息,或者在流通市场出售 变现。 资料显示,成都盟升电子技术股份有限公司(简称:盟升电子股票代码:688311.SH),是一家从事卫星导航、 卫星通信、电子对抗及数据链,终端产品研发、制造、销售及相关技术服务为一体的国家级专精特新"小 巨人"企业。 根据最新一期财务数据,2025年1月-3月,盟升电子实现营业收入2111.3万元,同比增加48.01%;归属 净利润-0.15亿元,同比增加30.88%;扣非净利润-0.195亿元,同比增加26.22%。 截至2025年3月,盟升电子筹码集中度非常集中。十大股东持股合计占比49.52%,十大流通股东持股合 计占比49.54%。股东人数6998户,人均流通股2.399万股,人均持股金额89.02万元。 8月26日,盟升转债盘中下跌2.01%报241.382元/张,成交额1.77亿元,转股溢价率20.32%。 资料显示,盟 ...